Pancreatic Cancer Research

ResearcherUniversity of PisaActive in the last 2 years

Pavel Vodička

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2376-1243; OpenAlex author ID A5004651940. Sources: OpenAlex.

Their work

Papers
27 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
81
Papers, trials and grants by year

2013: 3 papers · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 3 papers · 2020: 1 paper · 2021: 7 papers · 2022: 1 paper · 2023: 4 papers · 2024: none · 2025: 3 papers

Papers 27

  1. The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC. Co-author DOI 10.1016/j.semcancer.2025.05.004↗
  2. Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer. Last author DOI 10.1016/j.semcancer.2025.05.005↗
  3. A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/mutage/geae012↗
  4. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk. Co-author DOI 10.1002/ijc.34383↗
  5. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  6. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Co-author DOI 10.1016/j.dld.2023.02.023↗
  7. Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jmg-2022-108910↗
  8. Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium. Last author DOI 10.1158/1055-9965.epi-21-1340↗
  9. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.33475↗
  10. Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival. Co-author DOI 10.1038/s41598-021-87130-0↗
  11. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/carcin/bgab057↗
  12. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction. Co-author DOI 10.1136/jmedgenet-2020-106961↗
  13. Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0353↗
  14. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. Co-author DOI 10.3389/fgene.2021.693933↗
  15. Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk. Co-author DOI 10.3389/fonc.2021.771312↗
  16. Genome-wide association study identifies an early onset pancreatic cancer risk locus. Co-author DOI 10.1002/ijc.33004↗
  17. Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study. Co-author DOI 10.1002/ijc.31928↗
  18. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.32127↗
  19. Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients. Co-author DOI 10.1093/carcin/bgz006↗
  20. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation. Co-author DOI 10.1002/ijc.31047↗
  21. SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival. Co-author DOI 10.1038/srep43812↗
  22. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Co-author DOI 10.18632/oncotarget.10935↗
  23. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.29590↗
  24. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  25. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Co-author DOI 10.1016/j.dld.2012.09.014↗
  26. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Co-author DOI 10.1158/1055-9965.epi-12-1182↗
  27. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Co-author DOI 10.3892/or.2013.2285↗

Closest collaborators

The 25 strongest of 81 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniele Campa · 9 shared papers, 2013–2025 · strength 0.80
  2. Ľudmila Vodičková · 7 shared papers, 2013–2025 · strength 0.80
  3. Cosmeri Rizzato · 6 shared papers, 2013–2025 · strength 0.53
  4. Manuel Gentiluomo · 4 shared papers, 2019–2025 · strength 0.49
  5. Stefano Landi · 6 shared papers, 2013–2025 · strength 0.43
  6. Federico Canzian · 7 shared papers, 2013–2023 · strength 0.38
  7. Gabriele Capurso · 7 shared papers, 2013–2023 · strength 0.38
  8. Pavel Souček · 7 shared papers, 2013–2023 · strength 0.38
  9. Raffaele Pezzilli · 7 shared papers, 2013–2023 · strength 0.38
  10. John P. Neoptolemos · 6 shared papers, 2013–2023 · strength 0.34
  11. Francesca Tavano · 5 shared papers, 2013–2023 · strength 0.33
  12. Thilo Hackert · 4 shared papers, 2017–2023 · strength 0.31
  13. Riccardo Farinella · 2 shared papers, 2023–2025 · strength 0.31
  14. Lívia Archibugi · 2 shared papers, 2023–2025 · strength 0.31
  15. Beatrice Mohelníková-Duchoňová · 5 shared papers, 2013–2023 · strength 0.29
  16. Renata Talar‐Wojnarowska · 6 shared papers, 2013–2021 · strength 0.27
  17. Giulia Martina Cavestro · 3 shared papers, 2019–2023 · strength 0.27
  18. David J. Hughes · 2 shared papers, 2017–2025 · strength 0.24
  19. Rita Teresa Lawlor · 3 shared papers, 2017–2023 · strength 0.22
  20. Kari Hemminki · 1 shared paper, 2025 · strength 0.22
  21. Božena Smolková · 1 shared paper, 2025 · strength 0.22
  22. Saba Selvi · 1 shared paper, 2025 · strength 0.22
  23. Erika Halášová · 1 shared paper, 2025 · strength 0.22
  24. Eithne Costello · 4 shared papers, 2013–2021 · strength 0.21
  25. Oliver Strobel · 3 shared papers, 2017–2021 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.